BioSpace News Archive

BioMidwest

Athersys Licenses its Animal Health Assets to Ardent Animal Health

Athersys, Inc., a cell therapy and regenerative medicine company developing MultiStem® for critical care indications, and Multipotent Adult Progenitor Cell technology for equine, canine, and feline health applications, announces the signing of a licensing agreement with Ardent Animal Health.

October 3, 2023
·
10 min read
Lone Star Bio

Supreme Court Denies CareDx Request for Appeal in Patent Case with Natera

Natera, Inc., a global leader in cell-free DNA testing, announced that the United States Supreme Court denied CareDx, Inc.’s petition for certiorari concerning a patent infringement lawsuit brought by CareDx against Natera.

October 3, 2023
·
2 min read
Genetown

Takeda’s Dengue Vaccine Recommended by World Health Organization Advisory Group for Introduction in High Dengue Burden and Transmission Areas in Children Ages Six to 16 Years

Takeda announced that the World Health Organization’s Strategic Advisory Group of Experts on Immunization shared recommendations for use of QDENGA®▼.

October 3, 2023
·
16 min read
Studying Immune Cell Aging in Space May Lead to New Therapies for Patients on Earth

A healthy immune system is what defends the body from invaders like bacteria and viruses.

October 3, 2023
·
2 min read
FDA

EntroGen Receives FDA Approval for CRCdx® RAS Mutation Detection Kit as Companion Diagnostic for Vectibix®

The U.S. Food and Drug Administration has granted approval for EntroGen’s CRCdx® RAS Mutation Detection Kit as a companion diagnostic for Vectibix®, a targeted therapy used in the treatment of colorectal cancer.

October 3, 2023
·
2 min read